SCHEMBL4382760

SCHEMBL4382760

C=C1OC(=O)C(C)OC1=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15871607 1.00 CA1 (0.30) CA1CA9
SCHEMBL9971730 1.00 CA1 (0.30) CA1CA9
SCHEMBL22109888 0.83 CA1 (0.31) CA1CA9
SCHEMBL820409 0.77 CA1 (0.33) CA1CA9
SCHEMBL19213921 0.70
SCHEMBL1926425 0.69
SCHEMBL6794036 0.69
SCHEMBL981314 0.69
SCHEMBL20683302 0.68
SCHEMBL2860232 0.67 CA1 (0.41) CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116789943-A Unsaturated polylactic acid copolyester and preparation method thereof 浙江恒逸石化研究院有限公司 2023-09-22 CN claimed
US-8203007-B2 Bifunctional lactide monomer derivative and polymers and materials prepared using the same REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2012-06-19 US claimed
US-20090306333-A1 BIFUNCTIONAL LACTIDE MONOMER DERIVATIVE AND POLYMERS AND MATERIALS PREPARED USING THE SAME REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2009-12-10 US claimed
CN-116789943-B Unsaturated polylactic acid copolyester and preparation method thereof 浙江恒逸石化研究院有限公司 2025-10-21 CN disclosed
CN-116789943-A Unsaturated polylactic acid copolyester and preparation method thereof 浙江恒逸石化研究院有限公司 2023-09-22 CN disclosed
CN-116789943-A Unsaturated polylactic acid copolyester and preparation method thereof 浙江恒逸石化研究院有限公司 2023-09-22 CN disclosed
US-10954338-B2 Flame retardant lactide monomors for polylactide synthesis INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2021-03-23 US disclosed
US-10570252-B2 Flame retardant lactide monomors for polylactide synthesis INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-02-25 US disclosed
US-10329380-B2 Lactide-derived polymers with improved materials properties via polyhexahydrotriazines (PHT) reaction INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2019-06-25 US disclosed
EP-3362500-A1 ALIPHATIC POLY(ESTER)S WITH THIOL PENDANT GROUPS Novus Scientific AB (SE) 2018-08-22 EP disclosed
WO-2017064291-A1 ALIPHATIC POLY(ESTER)S WITH THIOL PENDANT GROUPS NOVUS SCIENTIFIC AB (SE) 2017-04-20 WO disclosed
US-9527939-B2 Lactide-based acrylate polymers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2016-12-27 US disclosed
US-20160215079-A1 LACTIDE-BASED ACRYLATE POLYMERS INTERNATIONAL BUSINESS MACHINES CORPORATION 2016-07-28 US disclosed
US-9260550-B1 Lactide-based acrylate polymers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2016-02-16 US disclosed
US-8203007-B2 Bifunctional lactide monomer derivative and polymers and materials prepared using the same REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2012-06-19 US disclosed
US-20090306333-A1 BIFUNCTIONAL LACTIDE MONOMER DERIVATIVE AND POLYMERS AND MATERIALS PREPARED USING THE SAME REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306333-A1 BIFUNCTIONAL LACTIDE MONOMER DERIVATIVE AND POLYMERS AND MATERIALS PREPARED USING THE SAME GNE, CAD, ILK CA1 1846/4885CA9 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.